Radient Pharmaceuticals Corp. (RPC) to Exhibit Cancer Test at Annual Leading Oncology Meeting in Chicago
Radient Pharmaceuticals Corp., a developer and global marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it will exhibit its Onko-Sure® cancer test at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from June 3-6, 2011. The Onko-Sure cancer test kit has been cleared by the FDA for colo-rectal cancer treatment and recurrence monitoring. The company will have the opportunity to discuss Onko-Sure and relative information with the thousands of oncology professionals at the meeting in Chicago. "Participating in ASCO 2011 is another step forward in increasing awareness of Onko-Sure through outreach to…